OCT angiography features associated with macular edema recurrence after intravitreal bevacizumab treatment in branch retinal vein occlusion
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Kwang-Eon | - |
dc.contributor.author | Yun, Cheolmin | - |
dc.contributor.author | Cha, Jaehyung | - |
dc.contributor.author | Kim, Seong-Woo | - |
dc.date.accessioned | 2021-09-01T04:43:38Z | - |
dc.date.available | 2021-09-01T04:43:38Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-10-02 | - |
dc.identifier.issn | 2045-2322 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/62549 | - |
dc.description.abstract | We aimed to evaluate the relationship between the capillary abnormalities including nonperfusion area (NPA) in optical coherence tomography angiography (OCTA) images and the recurrence of macular edema (ME) secondary to branch retinal vein occlusion (BRVO) after intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF; bevacizumab). The records of 40 patients who underwent intravitreal bevacizumab injection for ME secondary to BRVO and had at least six months of follow-up were reviewed. Central retinal thickness (CRT; mu m) and macular edema type were evaluated prior to treatment. After ME resolution, nonperfusion areas in the 1 mm (NPA1) and 1-3 mm (NPA3) zones on the Early Treatment Diabetic Retinopathy Study (ETDRS) circle within the superficial capillary plexus (SCP) and deep capillary plexus (DCP) were measured using OCTA images. Furthermore, other microvascular abnormalities in the both SCP and DCP were compared between groups. ME recurred in 25 of 40 (62.5%) eyes. The NPA1 of the SCP and DCP (p = 0.002, 0.004, respectively), NPA3 of the SCP and DCP (p = 0.002, 0.008, respectively), and initial CRT (p = 0.022) differed significantly between eyes with and without ME recurrence. In multivariate logistic regression analyses, the NPA1 of the DCP (OR: 344.718; p = 0.029) and NPA3 of the SCP (OR: 4.072; p = 0.018) were significantly associated with ME recurrence. Other microvascular abnormalities were not significantly different between two groups. The central NPA and parafoveal NPA of the SCP in OCTA images correlated strongly with ME recurrence in BRVO patients after intravitreal anti-VEGF injection. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.subject | OPTICAL COHERENCE TOMOGRAPHY | - |
dc.subject | ENDOTHELIAL GROWTH-FACTOR | - |
dc.subject | FOVEAL AVASCULAR ZONE | - |
dc.subject | RISK-FACTORS | - |
dc.subject | CAPILLARY NETWORK | - |
dc.subject | NATURAL-HISTORY | - |
dc.subject | EYES | - |
dc.subject | PATHOGENESIS | - |
dc.subject | RANIBIZUMAB | - |
dc.subject | DIAGNOSIS | - |
dc.title | OCT angiography features associated with macular edema recurrence after intravitreal bevacizumab treatment in branch retinal vein occlusion | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yun, Cheolmin | - |
dc.contributor.affiliatedAuthor | Kim, Seong-Woo | - |
dc.identifier.doi | 10.1038/s41598-019-50637-8 | - |
dc.identifier.scopusid | 2-s2.0-85072932818 | - |
dc.identifier.wosid | 000488481500016 | - |
dc.identifier.bibliographicCitation | SCIENTIFIC REPORTS, v.9 | - |
dc.relation.isPartOf | SCIENTIFIC REPORTS | - |
dc.citation.title | SCIENTIFIC REPORTS | - |
dc.citation.volume | 9 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.subject.keywordPlus | OPTICAL COHERENCE TOMOGRAPHY | - |
dc.subject.keywordPlus | ENDOTHELIAL GROWTH-FACTOR | - |
dc.subject.keywordPlus | FOVEAL AVASCULAR ZONE | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | CAPILLARY NETWORK | - |
dc.subject.keywordPlus | NATURAL-HISTORY | - |
dc.subject.keywordPlus | EYES | - |
dc.subject.keywordPlus | PATHOGENESIS | - |
dc.subject.keywordPlus | RANIBIZUMAB | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.